Greater Manchester Palliative Care Service
In April 2020, at the height of the COVID-19 pandemic when the country was in its first lockdown, ensuring access to palliative care medicines for end-of-life patients across Greater Manchester was a significant priority for the 10 GM CCGs.
In collaboration with the GMHSCP Primary Care team, an audit of existing commissioned palliative care stock holding services in community pharmacy was conducted by CHL, including the number of commissioned pharmacies per locality and the stock lists. A number of issues and concerns around current provision, stock lists, access, availability, and reporting were identified following the audit and feedback from commissioners. It was also identified that the NW region required reporting on stock at pharmacy level; CCGs needed up to date pharmacy information in order to complete the required report.
CHL prepared a standard offer to all 10 GM CCGs with a summary of the work to be completed, the timescales in which it would be delivered and a cost-effective standard fee for all. 6 of 10 GM CCGs took up the offer, with 2 CCGs opting for the enhanced service commissioned at tiers 2 and 3.
In collaboration with the LPCs and GMHSCP, CHL:
The work on the palliative care service for community pharmacy in GM was considered a significant contribution to the GM NHS at the height of the pandemic, and allowed CHL to clearly demonstrate to NHS commissioners our flexible and agile approach through: